Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia

Optimization of post‐remission therapies to maintain complete remission and prevent relapse is a major challenge in treating patients with acute myeloid leukemia (AML). Monitoring patients for measurable residual disease (MRD) is helpful to identify those at risk for relapse. Hypomethylating agents...

Full description

Saved in:
Bibliographic Details
Published in:Am J Hematol
Main Authors: Medeiros, Bruno C., Chan, Steven M., Daver, Naval G., Jonas, Brian A., Pollyea, Daniel A.
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Critical Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593671/
https://ncbi.nlm.nih.gov/pubmed/30945331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25484
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items